Welcome, Guest |
TOPIC:
100% - Dare to Dream The Impossible Dream 8 years 3 months ago #8462
The combination of Sofosbuvir and Daclatasvir provided pangenotyic treatment of HVC by inhibiting NS5B and NS5A. Simeprevir inhibits the NS3A/4 components: en.wikipedia.org/wiki/Simeprevir If you've been wondering if inhibiting NS3A/4 + NS5A + NS5B might work really well consider the IMPACT study that was reported at the AASLD November 2015 meeting - 100% might well be here: Before you get too excited there is no generic Simeprevir currently available and the cheapest price you might find it is for $7500 USD for 3x28 in Egypt, but it does look very promising. Note that Simeprevir is not active against GT3 and you don't want the Q80K mutation www.ncbi.nlm.nih.gov/pubmed/22326470 www.ncbi.nlm.nih.gov/pubmed/19852962 www.ncbi.nlm.nih.gov/pubmed/26392483 YMMV | |
Time to create page: 0.109 seconds